Christopher Kelly

Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON.

Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto.

Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA.

Part of Thermo Fisher Scientific, Inc., Medgenix Diagnostics SA is a Belgian company that specializes in making radioimmunology assays for in-vitro use. Medgenix Diagnostics was acquired by Biosource International, Inc. from MDS Nordion, Inc. on June 05, 1996 for $6.87 million.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Part of Thermo Fisher Scientific, Inc., IoDP Medical Imaging Research provides customized services for medical image analysis and image management in clinical trials to pharmaceutical and biotech companies, CROs, and public research organizations. The company is based in Sevres, France. IoDP Medical Imaging Research was acquired by Synexus Compass, Inc., part of Thermo Fisher Scientific, Inc. from September 03, 2019 on July 27, 2004.

Part of Gilead Sciences, Inc., DELEX Therapeutics, Inc. is a Canadian company that researches and develops inhalation pain treatment products for cancer patients. The company is based in Mississauga, Canada. DELEX Therapeutics was acquired by YM BioSciences, Inc. on May 03, 2005 for $7.60 million.

Part of Thermo Fisher Scientific, Inc., Ionalytics Corp. designs and manufactures ion-filtering equipment and related engineering instruments. The company is based in Ottawa, Canada. Ionalytics was acquired by Thermo Electron Corp. on August 11, 2005.

Part of Thermo Fisher Scientific, Inc., Center For Clinical & Basic Research is a Danish company that provides radiology services. The company is based in Ballerup, Denmark. The company was founded by Claus Henrik Christiansen. Center For Clinical & Basic Research was acquired by Synexus Compass, Inc., part of Thermo Fisher Scientific, Inc. from September 03, 2019 on July 14, 2006.

LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada.

Aerelink Ltd. provides wireless networking services. The private company is based in Widnes, UK. and has subsidiaries in United Kingdom.

Specialist Diabetes Research & Treatment Centre LLC specializes in diabetes treatment, research, training and public health awareness. Its services include diabetes, endocrinology, bariatric & metabolic, antenatal, cardiology, nephrology, podiatry, ophthalmology, radiology, dietetic services, laboratory, and pharmacy. The company was founded in May 2006 and is headquartered Abu Dhabi, United Arab Emirates.

Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London.

Microdermics, Inc. designs, builds, tests, and manufactures proprietary hollow metal microneedles that will eliminate the need for hypodermic needles for many therapeutics and traditional intramuscular vaccinations. It focuses on commercializing a novel hollow microneedle delivery platform targeting the multi-billion biopharmaceutical market. The company was founded by Sahan Ranamukharachchi, Iman Mansoor, Urs O. Häfeli, and Boris Stoeber in June 2014 and is headquartered in Vancouver, Canada.

Flosonics Medical develops and operates medical software platform for the management of critically ill patients. The company was founded by Joe Eibl, Jon-Emile Kenny, Andrew Eibl, and Sachit Harish and is headquartered in Sudbury, Canada.

Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada.

Empirica Therapeutics, Inc. develops novel allogeneic living drugs. The company was founded by Sheila Singh and Jason Moffat in July, 2018 and is headquartered in Hamilton, Canada.

adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada.

Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes.